应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ARCT Arcturus Therapeutics Ltd.
盘前交易 12-19 07:50:05 EST
14.82
-0.91
-5.79%
最高
16.13
最低
14.35
成交量
65.50万
今开
15.75
昨收
15.73
日振幅
11.32%
总市值
4.01亿
流通市值
3.68亿
总股本
2,709万
成交额
989.41万
换手率
2.64%
流通股本
2,480万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.79%报14.82美元
市场透视 · 03:54
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.79%报14.82美元
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.20%
市场透视 · 11-29
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.20%
Arcturus Therapeutics Holdings Inc.盘中异动 早盘快速上涨5.85%报17.90美元
市场透视 · 11-25
Arcturus Therapeutics Holdings Inc.盘中异动 早盘快速上涨5.85%报17.90美元
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大跌5.10%报16.20美元
市场透视 · 11-22
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大跌5.10%报16.20美元
Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.13%报17.00美元
市场透视 · 11-22
Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.13%报17.00美元
Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.12%报16.84美元
市场透视 · 11-18
Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.12%报16.84美元
Arcturus Therapeutics Holdings Inc.2024财年第三财季实现净利润-6.90百万美元,同比增加57.46%
市场透视 · 11-17
Arcturus Therapeutics Holdings Inc.2024财年第三财季实现净利润-6.90百万美元,同比增加57.46%
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大跌5.20%报19.31美元
市场透视 · 11-12
Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大跌5.20%报19.31美元
异动解读 | 分析师看好研发管线 Arcturus Therapeutics Holdings Inc.股价大涨10%
异动解读 · 11-12
异动解读 | 分析师看好研发管线 Arcturus Therapeutics Holdings Inc.股价大涨10%
异动解读 | Arcturus Therapeutics Holdings Inc.股价大涨 机构看好前景
异动解读 · 11-11
异动解读 | Arcturus Therapeutics Holdings Inc.股价大涨 机构看好前景
Arcturus Therapeutics Holdings Inc.盘中异动 快速拉升5.13%
市场透视 · 11-11
Arcturus Therapeutics Holdings Inc.盘中异动 快速拉升5.13%
Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速上涨5.07%报19.69美元
市场透视 · 11-08
Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速上涨5.07%报19.69美元
Arcturus Therapeutics Holdings Inc.盘中异动 早盘大幅上涨5.18%报19.30美元
市场透视 · 11-06
Arcturus Therapeutics Holdings Inc.盘中异动 早盘大幅上涨5.18%报19.30美元
Arcturus Therapeutics Holdings Inc.盘中异动 下午盘大幅下跌5.12%报18.14美元
市场透视 · 10-31
Arcturus Therapeutics Holdings Inc.盘中异动 下午盘大幅下跌5.12%报18.14美元
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.20%
市场透视 · 10-25
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.20%
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.08%报19.82美元
市场透视 · 10-23
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.08%报19.82美元
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.21%
市场透视 · 10-11
Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.21%
Arcturus Therapeutics Holdings Inc.盘中异动 临近收盘股价大跌5.15%
市场透视 · 10-09
Arcturus Therapeutics Holdings Inc.盘中异动 临近收盘股价大跌5.15%
Arcturus Therapeutics Holdings Inc.盘中异动 大幅上涨5.08%报23.15美元
市场透视 · 09-30
Arcturus Therapeutics Holdings Inc.盘中异动 大幅上涨5.08%报23.15美元
Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.09%
市场透视 · 09-24
Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.09%
加载更多
公司概况
公司名称:
Arcturus Therapeutics Ltd.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Arcturus Therapeutics Holdings Inc.在以色列注册,并于2008年2月7日开始运营。该公司是一家新兴生物制药公司,主要致力于治疗神经干扰的专利药物开发与商业化,比如注意力缺陷多动症。公司正对药物MG01C1进行更多的临床试验,如果试验成功将向美国食品药品管理局和其他国家的监管机构申请销售。公司还没有通过销售产品取得收入,也不预期产生巨大收入,除非MG01C1获得销售许可并且商业化。因此,公司尚处于发展阶段,正如ASC所定义的“发展阶段实体”。
发行价格:
--
{"stockData":{"symbol":"ARCT","market":"US","secType":"STK","nameCN":"Arcturus Therapeutics Ltd.","latestPrice":14.82,"timestamp":1734555600000,"preClose":15.73,"halted":0,"volume":655016,"delay":0,"floatShares":24801158,"shares":27087359,"eps":-2.329253,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.91,"latestTime":"12-19 07:50:05 EST","open":15.75,"high":16.13,"low":14.35,"amount":9894132.617832,"amplitude":0.11316,"askPrice":17.17,"askSize":100,"bidPrice":14.41,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-2.329253,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"adjPreClose":14.82,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":15.5,"preClose":14.82,"latestTime":"19:49 EST","volume":16152,"amount":240140.9996,"timestamp":1734569392741},"volumeRatio":1.784759453680401,"impliedVol":0.8883,"impliedVolPercentile":0.8406},"requestUrl":"/m/hq/s/ARCT","defaultTab":"news","newsList":[{"id":"2492195153","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.79%报14.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492195153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492195153?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:54","pubTimestamp":1734551695,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时54分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价急速下挫5.79%。截至发稿,该股报14.82美元/股,成交量30.6008万股,换手率1.13%,振幅7.41%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为1.95%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903550395ea5997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121903550395ea5997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0},{"id":"2487569555","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487569555","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487569555?lang=zh_cn&edition=full","pubTime":"2024-11-29 23:57","pubTimestamp":1732895861,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日23时57分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价急速上涨5.20%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129235741abe910fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129235741abe910fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2486408023","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘快速上涨5.85%报17.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486408023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486408023?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:41","pubTimestamp":1732545704,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时41分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价急速上涨5.85%。截至发稿,该股报17.90美元/股,成交量2.0472万股,换手率0.08%,振幅1.89%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.65%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224144971a8604&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224144971a8604&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2485267380","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大跌5.10%报16.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485267380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485267380?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:38","pubTimestamp":1732286296,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时38分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价大幅下跌5.10%。截至发稿,该股报16.20美元/股,成交量1.8864万股,换手率0.07%,振幅3.16%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223816abd79505&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223816abd79505&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2485446198","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.13%报17.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485446198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485446198?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:30","pubTimestamp":1732213833,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时30分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价急速拉升5.13%。截至发稿,该股报17.00美元/股,成交量20.0664万股,换手率0.74%,振幅9.00%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122023033abd54a00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122023033abd54a00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ","BK4139"],"gpt_icon":0},{"id":"2484677120","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.12%报16.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484677120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484677120?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:47","pubTimestamp":1731944845,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时47分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价快速上涨5.12%。截至发稿,该股报16.84美元/股,成交量17.8994万股,换手率0.66%,振幅6.84%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.11%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823472598e434ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111823472598e434ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2484696543","title":"Arcturus Therapeutics Holdings Inc.2024财年第三财季实现净利润-6.90百万美元,同比增加57.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484696543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484696543?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731773038,"startTime":"0","endTime":"0","summary":"11月17日,Arcturus Therapeutics Holdings Inc.公布财报,公告显示公司2024财年第三财季净利润为-6.90百万美元,同比增加57.46%;其中营业收入为38.82百万美元,同比减少10.51%,每股基本收益为-0.26美元。机构评级:截至2024年11月17日,当前有9家机构对Arcturus Therapeutics Holdings Inc.目标价做出预测,其中目标均价为77.36美元,其中最低目标价为25.00美元,最高目标价为140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000517a23e078c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000517a23e078c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ"],"gpt_icon":0},{"id":"2482085931","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大跌5.20%报19.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085931?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:38","pubTimestamp":1731422303,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时38分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价快速下挫5.20%。截至发稿,该股报19.31美元/股,成交量2.174万股,换手率0.08%,振幅3.02%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.08%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223823971a602a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223823971a602a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"gpt_icon":0},{"id":"1191213809","title":"异动解读 | 分析师看好研发管线 Arcturus Therapeutics Holdings Inc.股价大涨10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191213809","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191213809?lang=zh_cn&edition=full","pubTime":"2024-11-12 05:04","pubTimestamp":1731359085,"startTime":"0","endTime":"0","summary":"生物技术公司Arcturus Therapeutics Holdings Inc.在2024年11月11日出现了近10%的大涨行情,引发了市场的广泛关注。此次股价大涨与公司最新财报数据以及机构分析师的看好评级密切相关。就在前一日晚间,Arcturus Therapeutics公布了第三季度财报。多位分析师指出,Arcturus Therapeutics在核酸药物技术上拥有先发优势和领先地位,加上多样化的产品管线覆盖了多个热门疾病领域,前景值得期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARCT"],"gpt_icon":0},{"id":"1146189782","title":"异动解读 | Arcturus Therapeutics Holdings Inc.股价大涨 机构看好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1146189782","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146189782?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:45","pubTimestamp":1731336316,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日,生物技术公司Arcturus Therapeutics Holdings Inc.(ARCT)股价盘中大涨5.13%,引发市场关注。\n\n公司最新财报显示,第三季度营收3882万美元,环比增长38%;净利润亏损690万美元,亏损有所扩大。尽管亏损加大,但分析人士认为,公司在罕见疾病领域的产品线前景广阔,有望带动长期收入增长。\n\n另一利好因素是,目前参与评级的11家机构均给予买入评级,看好公司长期投资价值。一些分析指出,公司专注RNA药物研发,在肝脏和呼吸系统等疾病领域拥有多个在研产品,未来发展值得期待。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARCT"],"gpt_icon":0},{"id":"2482738813","title":"Arcturus Therapeutics Holdings Inc.盘中异动 快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738813?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:37","pubTimestamp":1731335871,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时37分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价急速拉升5.13%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.33%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223751a22ce7e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223751a22ce7e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"gpt_icon":0},{"id":"2481029301","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速上涨5.07%报19.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481029301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481029301?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076363,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价急速上涨5.07%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Fortrea Holdings Inc.、Tenaya Therapeutics, Inc.、Rigel Pharmaceuticals, Inc.涨幅较大,Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃,换手率分别为383.72%、16.45%、14.03%,振幅较大的相关个股有Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.、Cardiff Oncology, Inc.,振幅分别为16.51%、14.96%、14.91%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223243a224c385&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108223243a224c385&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2481898364","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘大幅上涨5.18%报19.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481898364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481898364?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903557,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价急速上涨5.18%。截至发稿,该股报19.30美元/股,成交量1.4245万股,换手率0.05%,振幅0.87%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.49%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223238971a4bfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223238971a4bfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARCT","LENZ"],"gpt_icon":0},{"id":"2479305647","title":"Arcturus Therapeutics Holdings Inc.盘中异动 下午盘大幅下跌5.12%报18.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479305647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479305647?lang=zh_cn&edition=full","pubTime":"2024-10-31 01:35","pubTimestamp":1730309747,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日01时35分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价急速下跌5.12%。截至发稿,该股报18.14美元/股,成交量9.5283万股,换手率0.35%,振幅4.24%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.21%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103101354798e3f79b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103101354798e3f79b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"gpt_icon":0},{"id":"2478657096","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478657096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478657096?lang=zh_cn&edition=full","pubTime":"2024-10-25 01:55","pubTimestamp":1729792507,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日01时55分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价快速跳水5.20%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.07%。其相关个股中,Monopar Therapeutics Inc.、Quince Therapeutics, Inc.、Aligos Therapeutics, Inc.涨幅较大,Monopar Therapeutics Inc.、Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为295.18%、284.23%、198.03%,振幅较大的相关个股有Monopar Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Qualigen Therapeutics, Inc.,振幅分别为679.91%、78.77%、71.78%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025015507971a21fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025015507971a21fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0},{"id":"2477646893","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.08%报19.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477646893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477646893?lang=zh_cn&edition=full","pubTime":"2024-10-23 02:48","pubTimestamp":1729622880,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日02时48分,Arcturus Therapeutics Holdings Inc.股票出现波动,股价急速下跌5.08%。截至发稿,该股报19.82美元/股,成交量11.0325万股,换手率0.41%,振幅3.86%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.84%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102302480198e3dd32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102302480198e3dd32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2474724174","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474724174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474724174?lang=zh_cn&edition=full","pubTime":"2024-10-11 00:58","pubTimestamp":1728579510,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日00时58分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价快速下挫5.21%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.37%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110058309719f8fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110058309719f8fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"gpt_icon":0},{"id":"2474288316","title":"Arcturus Therapeutics Holdings Inc.盘中异动 临近收盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474288316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474288316?lang=zh_cn&edition=full","pubTime":"2024-10-09 03:31","pubTimestamp":1728415916,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日03时31分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价大幅下挫5.15%。截至发稿,该股报22.64美元/股,成交量12.3061万股,换手率0.46%,振幅4.88%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009033157a1df17fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009033157a1df17fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0},{"id":"2471938631","title":"Arcturus Therapeutics Holdings Inc.盘中异动 大幅上涨5.08%报23.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471938631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471938631?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:57","pubTimestamp":1727704630,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时57分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价快速拉升5.08%。截至发稿,该股报23.15美元/股,成交量2.8395万股,换手率0.11%,振幅7.01%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.33%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930215711a1ddb57f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240930215711a1ddb57f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ARCT"],"gpt_icon":0},{"id":"2469219741","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469219741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469219741?lang=zh_cn&edition=full","pubTime":"2024-09-24 02:53","pubTimestamp":1727117609,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日02时53分,Arcturus Therapeutics Holdings Inc.股票出现异动,股价急速拉升5.09%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中,整体跌幅为1.98%。Arcturus Therapeutics Holdings Inc.公司简介:Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司,专注于罕见疾病领域的研究机会,目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924025330a1dbf603&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924025330a1dbf603&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ARCT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcturusrx.com","stockEarnings":[{"period":"1week","weight":-0.1744},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.295},{"period":"6month","weight":-0.4601},{"period":"1year","weight":-0.5427},{"period":"ytd","weight":-0.53}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcturus Therapeutics Holdings Inc.在以色列注册,并于2008年2月7日开始运营。该公司是一家新兴生物制药公司,主要致力于治疗神经干扰的专利药物开发与商业化,比如注意力缺陷多动症。公司正对药物MG01C1进行更多的临床试验,如果试验成功将向美国食品药品管理局和其他国家的监管机构申请销售。公司还没有通过销售产品取得收入,也不预期产生巨大收入,除非MG01C1获得销售许可并且商业化。因此,公司尚处于发展阶段,正如ASC所定义的“发展阶段实体”。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.080132},{"month":2,"riseRate":0.545455,"avgChangeRate":0.011691},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.021161},{"month":4,"riseRate":0.545455,"avgChangeRate":0.101832},{"month":5,"riseRate":0.636364,"avgChangeRate":0.1056},{"month":6,"riseRate":0.583333,"avgChangeRate":0.023074},{"month":7,"riseRate":0.583333,"avgChangeRate":0.109538},{"month":8,"riseRate":0.5,"avgChangeRate":0.045801},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.063785},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.046065},{"month":11,"riseRate":0.666667,"avgChangeRate":0.063018},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.071811}],"exchange":"NASDAQ","name":"Arcturus Therapeutics Ltd.","nameEN":"Arcturus Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcturus Therapeutics Ltd.,ARCT,Arcturus Therapeutics Ltd.股票,Arcturus Therapeutics Ltd.股票老虎,Arcturus Therapeutics Ltd.股票老虎国际,Arcturus Therapeutics Ltd.行情,Arcturus Therapeutics Ltd.股票行情,Arcturus Therapeutics Ltd.股价,Arcturus Therapeutics Ltd.股市,Arcturus Therapeutics Ltd.股票价格,Arcturus Therapeutics Ltd.股票交易,Arcturus Therapeutics Ltd.股票购买,Arcturus Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}